Faulkner-Jones, A.; Zamora, V.; Hortigon-Vinagre, M.P.; Wang, W.; Ardron, M.; Smith, G.L.; Shu, W.
A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation. Bioengineering 2022, 9, 32.
https://doi.org/10.3390/bioengineering9010032
AMA Style
Faulkner-Jones A, Zamora V, Hortigon-Vinagre MP, Wang W, Ardron M, Smith GL, Shu W.
A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation. Bioengineering. 2022; 9(1):32.
https://doi.org/10.3390/bioengineering9010032
Chicago/Turabian Style
Faulkner-Jones, Alan, Victor Zamora, Maria P. Hortigon-Vinagre, Wenxing Wang, Marcus Ardron, Godfrey L. Smith, and Wenmiao Shu.
2022. "A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation" Bioengineering 9, no. 1: 32.
https://doi.org/10.3390/bioengineering9010032
APA Style
Faulkner-Jones, A., Zamora, V., Hortigon-Vinagre, M. P., Wang, W., Ardron, M., Smith, G. L., & Shu, W.
(2022). A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation. Bioengineering, 9(1), 32.
https://doi.org/10.3390/bioengineering9010032
